Treatment of Insomnia (difficult to fall/ stay asleep) with Unani medicine Raughan-e-Banafsha

An Open-Label, Multicenteric Clinical Validation Study to Evaluate the efficacy and Safety of Unani Pharmacopoeial formulationâ?? Raughan-e-Banafsha in Sahar (Insomnia)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/05/033885

Enrollment

220

Registered

2021-05-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G470- Insomnia

Interventions

Intervention1: Raughan-e-Banafsha: 5ml oil topically once at night on the scalp for minimum 10 minutes for 2 weeks Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects of both the sexes between the age group of 18 to 65 years. 2. Subjects with Primary Insomnia(which is not attributable to medical, psychiatric and any environmental cause).

Exclusion criteria

Exclusion criteria: 1. Subjects with known psychiatric illness, Mental and Cardiac diseases. 2. Subjects with COPD, Migraine, cluster Headache,Parkinson, Chorea,Epilepsy, Dementia. 3. Subjects with skin disorders viz. Eczema,Scabies, and Psoriasis. 4. Subjects with any sedatives or anti-histaminics and glucocorticoids 5.Pregnant and Lactating females 6. Subjects who are not willing to take part in the study.

Design outcomes

Primary

Measure	Time frame
Improvement in sign and symptoms of Sahar (Insomnia)Timepoint: 1week	—

Secondary

Measure	Time frame
Haematological and biochemical assessment for safety assessment Timepoint: After two weeks of starting treatment	—

Countries

India

Contacts

Public ContactDr Pradeep Kumar

Central Council for Research in Unani Medicine (CCRUM)

ccrum507@rediffmail.com9213511298

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026